Spaces:
Sleeping
Sleeping
Update app.py
Browse files
app.py
CHANGED
@@ -66,7 +66,7 @@ def visualize_entities(sentence):
|
|
66 |
|
67 |
import gradio as gr
|
68 |
|
69 |
-
|
70 |
"The BCR::ABL1 tyrosine kinase protein is significant in the context of Imatinib therapy for chronic myeloid leukemia (CML) due to its role as the target of Imatinib, which inhibits its activity and helps control the progression of CML.",
|
71 |
"Famotidine is a histamine H2-receptor antagonist used in inpatient settings for the prevention of stress ulcers and is gaining popularity due to its low cost and effectiveness in reducing gastric acid secretion.",
|
72 |
"A randomized Phase III trial demonstrated noninferiority of APF530 500 mg SC (granisetron 10 mg) to intravenous palonosetron 0.25 mg in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic chemotherapy (MEC or HEC) in both acute (0 - 24 hours) and delayed (24 - 120 hours) settings, with sustained activity over 120 hours.",
|
|
|
66 |
|
67 |
import gradio as gr
|
68 |
|
69 |
+
exampleList = [
|
70 |
"The BCR::ABL1 tyrosine kinase protein is significant in the context of Imatinib therapy for chronic myeloid leukemia (CML) due to its role as the target of Imatinib, which inhibits its activity and helps control the progression of CML.",
|
71 |
"Famotidine is a histamine H2-receptor antagonist used in inpatient settings for the prevention of stress ulcers and is gaining popularity due to its low cost and effectiveness in reducing gastric acid secretion.",
|
72 |
"A randomized Phase III trial demonstrated noninferiority of APF530 500 mg SC (granisetron 10 mg) to intravenous palonosetron 0.25 mg in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic chemotherapy (MEC or HEC) in both acute (0 - 24 hours) and delayed (24 - 120 hours) settings, with sustained activity over 120 hours.",
|